Serotonin and molecular neuroimaging in humans using PET

The serotonergic system is one of the most important modulatory neurotransmitter systems in the human brain. It plays a central role in major physiological processes and is implicated in a number of psychiatric disorders. Along with the dopaminergic system, it is also one of the phylogenetically oldest human neurotransmitter systems and one of the most diverse, with 14 different receptors identified up to this day, many of whose function remains to be understood. The system’s functioning is even more diverse than the number of its receptors, since each is implicated in a number of different processes. This review aims at illustrating the distribution and summarizing the main functions of the serotonin (5-hydroxytryptamin, 5-HT) receptors as well as the serotonin transporter (SERT, 5-HTT), the vesicular monoamine transporter 2, monoamine oxidase type A and 5-HT synthesis in the human brain. Recent advances in in vivo quantification of these different receptors and enzymes that are part of the serotonergic system using positron emission tomography are described.

[1]  W. Danysz,et al.  Effects of 5-HT6 antagonists, Ro-4368554 and SB-258585, in tests used for the detection of cognitive enhancement and antipsychotic-like activity , 2011, Behavioural pharmacology.

[2]  P. Blier,et al.  Pharmacological Blockade of 5-HT7 Receptors as a Putative Fast Acting Antidepressant Strategy , 2011, Neuropsychopharmacology.

[3]  Gitte M Knudsen,et al.  Measuring Endogenous 5-HT Release by Emission Tomography: Promises and Pitfalls , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[4]  I. Page,et al.  Serotonin content of some mammalian tissues and urine and a method for its determination. , 1953, The American journal of physiology.

[5]  Claus Svarer,et al.  Cortical and Subcortical 5-HT2A Receptor Binding in Neuroleptic-Naive First-Episode Schizophrenic Patients , 2008, Neuropsychopharmacology.

[6]  Rupert Lanzenberger,et al.  Central serotonin 1A receptor binding in temporal lobe epilepsy: A [carbonyl-11 C]WAY-100635 PET study , 2010, Epilepsy & Behavior.

[7]  Wolfgang Wadsak,et al.  Reduced Serotonin-1A Receptor Binding in Social Anxiety Disorder , 2007, Biological Psychiatry.

[8]  K. Wimalasena Vesicular monoamine transporters: Structure‐function, pharmacology, and medicinal chemistry , 2011, Medicinal research reviews.

[9]  Alan A. Wilson,et al.  Imaging the serotonin transporter with positron emission tomography: initial human studies with [11C]DAPP and [11C]DASB , 2000, European Journal of Nuclear Medicine.

[10]  Alan A. Wilson,et al.  Relationship of monoamine oxidase A binding to adaptive and maladaptive personality traits , 2010, Psychological Medicine.

[11]  M. Nishikawa,et al.  Increasing blood oxygen increases an index of 5-HT synthesis in human brain as measured using α-[11C]methyl-l-tryptophan and positron emission tomography , 2005, Neurochemistry International.

[12]  R. Parsey,et al.  Synthesis and in vivo evaluation of [O-methyl-11C] N-[3,5-dichloro-2-(methoxy)phenyl]-4-(methoxy)-3-(1-piperazinyl)benzenesulfonamide as an imaging probe for 5-HT6 receptors. , 2011, Bioorganic & medicinal chemistry.

[13]  R. Eglen,et al.  The pharmacology and distribution of human 5‐hydroxytryptamine2B (5‐HT2b) receptor gene products: comparison with 5‐HT2a and 5‐HT2c receptors , 1995, British journal of pharmacology.

[14]  T. Machu Therapeutics of 5-HT3 receptor antagonists: current uses and future directions. , 2011, Pharmacology & therapeutics.

[15]  Feng,et al.  Synthesis of a New , 2001 .

[16]  M. Didriksen,et al.  Effects of the 5-HT6 receptor antagonist, SB-271046, in animal models for schizophrenia , 2002, Pharmacology Biochemistry and Behavior.

[17]  R. Wise,et al.  Elevated Expression of 5-HT1B Receptors in Nucleus Accumbens Efferents Sensitizes Animals to Cocaine , 2002, The Journal of Neuroscience.

[18]  O. Curet,et al.  Mapping the Cerebral Monoamine Oxidase Type A: Positron Emission Tomography Characterization of the Reversible Selective Inhibitor [11C]Befloxatone , 2003, Journal of Pharmacology and Experimental Therapeutics.

[19]  C. Marsden,et al.  Influence of social isolation in the rat on serotonergic function and memory – Relevance to models of schizophrenia and the role  of 5-HT6 receptors , 2011, Neuropharmacology.

[20]  Junchao Tong,et al.  Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease. , 2007, Brain : a journal of neurology.

[21]  W. van den Brink,et al.  Serotonin and dopamine transporters in relation to neuropsychological functioning, personality traits and mood in young adult healthy subjects , 2010, Psychological Medicine.

[22]  A. van Waarde,et al.  Measuring serotonin synthesis: from conventional methods to PET tracers and their (pre)clinical implications , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[23]  R. Kvetňanský,et al.  Vesicular Monoamine Transporters (VMATs) in Adrenal Chromaffin Cells: Stress-Triggered Induction of VMAT2 and Expression in Epinephrine Synthesizing Cells , 2010, Cellular and Molecular Neurobiology.

[24]  David Julius,et al.  Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors , 1995, Nature.

[25]  Laurent Descarries,et al.  Decreased [18F]MPPF Binding Potential in the Dorsal Raphe Nucleus After a Single Oral Dose of Fluoxetine: A Positron-Emission Tomography Study in Healthy Volunteers , 2008, Biological Psychiatry.

[26]  G. Mcallister,et al.  The hypothermic effect of 5-CT in mice is mediated through the 5-HT7 receptor , 2003, Neuropharmacology.

[27]  A. Meneses Effects of the 5-HT6 receptor antagonist Ro 04-6790 on learning consolidation , 2001, Behavioural Brain Research.

[28]  Kirk W. Johnson,et al.  5‐HT1F receptor agonists inhibit neurogenic dural inflammation in guinea pigs , 1997, Neuroreport.

[29]  Rupert Lanzenberger,et al.  Aggression is related to frontal serotonin‐1A receptor distribution as revealed by PET in healthy subjects , 2009, Human brain mapping.

[30]  R. Hen,et al.  Attenuated Response to Stress and Novelty and Hypersensitivity to Seizures in 5-HT4 Receptor Knock-Out Mice , 2004, The Journal of Neuroscience.

[31]  C. Rowe,et al.  In vivo assessment of vesicular monoamine transporter type 2 in dementia with lewy bodies and Alzheimer disease. , 2011, Archives of neurology.

[32]  H. Kung,et al.  Amino- and amido-tetrabenazine derivatives: synthesis and evaluation as potential ligands for the vesicular monoamine transporter. , 1995, Nuclear medicine and biology.

[33]  M. Erlander,et al.  A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms , 1993, Neuron.

[34]  U. Reuter,et al.  5-HT1F receptor agonists: A new treatment option for migraine attacks? , 2010, Neurotherapeutics.

[35]  Yiyun Huang,et al.  Development of effective PET and SPECT imaging agents for the serotonin transporter: has a twenty-year journey reached its destination? , 2010, Current topics in medicinal chemistry.

[36]  C. Halldin,et al.  Dose-dependent binding of AZD3783 to brain 5-HT1B receptors in non-human primates and human subjects: a positron emission tomography study with [11C]AZ10419369 , 2011, Psychopharmacology.

[37]  S. Gambhir,et al.  Molecular imaging in living subjects: seeing fundamental biological processes in a new light. , 2003, Genes & development.

[38]  Mark Slifstein,et al.  Serotonin transporters in obsessive-compulsive disorder: a positron emission tomography study with [11C]McN 5652 , 2003, Biological Psychiatry.

[39]  A. Wesołowska,et al.  Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression , 2006, Neuropharmacology.

[40]  S. Mace,et al.  Selective serotonin reuptake inhibitors: a review of efficacy and tolerability in depression , 2000, Expert opinion on pharmacotherapy.

[41]  N. Volkow,et al.  Monoamine oxidase: radiotracer development and human studies. , 2000, Methods.

[42]  Franz X Vollenweider,et al.  Serotonin research: contributions to understanding psychoses. , 2008, Trends in pharmacological sciences.

[43]  David R. Thomas,et al.  5-ht5A receptors as a therapeutic target. , 2006, Pharmacology & therapeutics.

[44]  Yiyun Huang,et al.  Serotonin 1B Receptor Imaging in Alcohol Dependence , 2009, Biological Psychiatry.

[45]  A. Varghese,et al.  The serotonin transporter: a vehicle to elucidate pulmonary hypertension? , 2004, Circulation research.

[46]  G. Kirov,et al.  Case-control association study of 65 candidate genes revealed a possible association of a SNP of HTR5A to be a factor susceptible to bipolar disease in Bulgarian population. , 2009, Journal of affective disorders.

[47]  Á. Pazos,et al.  Autoradiographic distribution of 5‐HT7 receptors in the human brain using [3H]mesulergine: comparison to other mammalian species , 2004, British journal of pharmacology.

[48]  W. Mcbride,et al.  Serotonin-3 receptors in the posterior ventral tegmental area regulate ethanol self-administration of alcohol-preferring (P) rats. , 2010, Alcohol.

[49]  C. Halldin,et al.  Quantitative analysis of ( 11 C)AZ10419369 binding to 5-HT 1B receptors in human brain , 2011 .

[50]  A. Serretti,et al.  The 5-HT2C receptor as a target for mood disorders , 2004, Expert opinion on therapeutic targets.

[51]  G. Hutchins,et al.  Synthesis of new carbon-11 labeled benzoxazole derivatives for PET imaging of 5-HT(3) receptor. , 2008, European journal of medicinal chemistry.

[52]  A. Meneses,et al.  Stimulation of 5-HT1A, 5-HT1B, 5-HT2A/2C, 5-HT3 and 5-HT4 receptors or 5-HT uptake inhibition: Short- and long-term memory , 2007, Behavioural Brain Research.

[53]  G. Debonnel,et al.  Selective Serotonin Reuptake Inhibitors Potentiate the Rapid Antidepressant-Like Effects of Serotonin4 Receptor Agonists in the Rat , 2010, PloS one.

[54]  P. Marin,et al.  GPCR interacting proteins (GIPs) in the nervous system: Roles in physiology and pathologies. , 2010, Annual review of pharmacology and toxicology.

[55]  M. Millan,et al.  Differential influence of selective 5-HT5A vs 5-HT1A, 5-HT1B, or 5-HT2C receptor blockade upon light-induced phase shifts in circadian activity rhythms: Interaction studies with citalopram , 2009, European Neuropsychopharmacology.

[56]  O Muzik,et al.  Human brain serotonin synthesis capacity measured in vivo with alpha-[C-11]methyl-L-tryptophan. , 1998, Synapse.

[57]  Paul J. Harrison,et al.  5-HT1A and 5-HT2A Receptor mRNAs and Binding Site Densities Are Differentially Altered in Schizophrenia , 1996, Neuropsychopharmacology.

[58]  L. Daws,et al.  Ontogeny and regulation of the serotonin transporter: providing insights into human disorders. , 2011, Pharmacology & therapeutics.

[59]  Claus Svarer,et al.  Cerebral serotonin transporter binding is inversely related to body mass index , 2010, NeuroImage.

[60]  Rupert Lanzenberger,et al.  Differences in the dynamics of serotonin reuptake transporter occupancy may explain superior clinical efficacy of escitalopram versus citalopram , 2009, International clinical psychopharmacology.

[61]  P. Cowen,et al.  Brain serotonin transporter binding in former users of MDMA ('ecstasy'). , 2009, The British journal of psychiatry : the journal of mental science.

[62]  M. Leopoldo,et al.  The serotonin 5-HT7 receptor agonist LP-44 microinjected into the dorsal raphe nucleus suppresses REM sleep in the rat , 2008, Behavioural Brain Research.

[63]  R. Koeppe,et al.  In vivo imaging of the brain vesicular monoamine transporter. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[64]  J. Halford The Role of Serotonin in Eating Behavior: Focus on 5-HT2C Receptors , 2011 .

[65]  Á. Pazos,et al.  Differential Distribution of [3H]Sumatriptan Binding Sites (5-HT1B, 5-HT1D and 5-HT1F Receptors) in Human Brain: Focus on Brainstem and Spinal Cord , 1997, Neuropharmacology.

[66]  Z. Bhagwagar,et al.  The 5-HT1B receptor: a novel target for the pathophysiology of depression. , 2009, Current drug targets.

[67]  Joel Paris,et al.  Brain Regional α-[11C]Methyl-l-Tryptophan Trapping in Impulsive Subjects With Borderline Personality Disorder , 2001 .

[68]  I. Martin,et al.  Molecular biology of 5-HT receptors , 1994, Neuropharmacology.

[69]  F. Lezoualc’h,et al.  Design, synthesis, and biological evaluation of new 5-HT4 receptor agonists: application as amyloid cascade modulators and potential therapeutic utility in Alzheimer's disease. , 2009, Journal of medicinal chemistry.

[70]  R Todd Ogden,et al.  In vivo Serotonin-Sensitive Binding of [11C]CUMI-101: A Serotonin 1A Receptor Agonist Positron Emission Tomography Radiotracer , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[71]  Juha Markkula,et al.  Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635. , 2008, The international journal of neuropsychopharmacology.

[72]  N. Costes,et al.  Brainstem changes in 5-HT1A receptor availability during migraine attack , 2011, Cephalalgia : an international journal of headache.

[73]  B. Herpertz-Dahlmann,et al.  5-HT2A promoter polymorphism −1438G/A in children and adolescents with obsessive-compulsive disorders , 2002, Molecular Psychiatry.

[74]  M Diksic,et al.  Differences between males and females in rates of serotonin synthesis in human brain. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[75]  D. Weinberger,et al.  Central serotonin transporter levels are associated with stress hormone response and anxiety , 2011, Psychopharmacology.

[76]  J. Palacios,et al.  Serotonin receptors in the human brain—IV. Autoradiographic mapping of serotonin-2 receptors , 1987, Neuroscience.

[77]  John F. G. Atack,et al.  Serotonin Transporter , 2021, Encyclopedia of Evolutionary Psychological Science.

[78]  B. Mcwilliams,et al.  Cognitive Function , 2021, Encyclopedia of Gerontology and Population Aging.

[79]  D. E. Kuhl,et al.  Kinetic Evaluation of [11C]Dihydrotetrabenazine by Dynamic PET: Measurement of Vesicular Monoamine Transporter , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[80]  M. Ramírez,et al.  5-HT(6) receptor and cognition. , 2011, Current opinion in pharmacology.

[81]  D. Collier,et al.  5-HT2A and 5-HT2C receptor polymorphisms and psychopathology in late onset Alzheimer's disease. , 1998, Human molecular genetics.

[82]  S Kasper,et al.  Influence of escitalopram treatment on 5-HT1A receptor binding in limbic regions in patients with anxiety disorders , 2009, Molecular Psychiatry.

[83]  Gwenn S. Smith,et al.  Functional neuroimaging in geriatric depression. , 2011, The Psychiatric clinics of North America.

[84]  Markus Piel,et al.  18F-labeling and evaluation of novel MDL 100907 derivatives as potential 5-HT2A antagonists for molecular imaging. , 2010, Nuclear medicine and biology.

[85]  L. Marner,et al.  Cerebral serotonin 4 receptors and amyloid-β in early Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.

[86]  A. Roberts,et al.  The 5‐HT7 receptor in learning and memory , 2012, Hippocampus.

[87]  B. Gulyás,et al.  Development of a PET radioligand for the central 5-HT1B receptor: radiosynthesis and characterization in cynomolgus monkeys of eight radiolabeled compounds. , 2011, Nuclear medicine and biology.

[88]  R. Regenthal,et al.  The serotonin transporter availability in untreated early-onset and late-onset patients with obsessive-compulsive disorder. , 2011, The international journal of neuropsychopharmacology.

[89]  Sylvain Houle,et al.  Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression. , 2006, Archives of general psychiatry.

[90]  C. D. Arnett,et al.  Mapping human brain monoamine oxidase A and B with 11C-labeled suicide inactivators and PET. , 1987, Science.

[91]  P. Cumming,et al.  Effects of monoamine inhibition on amphetamine-evoked changes in dopamine receptor availability in living pig: A dual tracer PET study with 11C-harmine and 11C-raclopride , 2006 .

[92]  D. Nutt,et al.  Serotonin 5-HT1A receptor binding in people with panic disorder: positron emission tomography study. , 2008, The British journal of psychiatry : the journal of mental science.

[93]  H. Kung,et al.  In vivo studies of the SERT-selective [18F]FPBM and VMAT2-selective [18F]AV-133 radiotracers in a rat model of Parkinson's disease. , 2010, Nuclear medicine and biology.

[94]  Claus Svarer,et al.  Patients with obsessive-compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei. , 2005, The international journal of neuropsychopharmacology.

[95]  Yogesh K. Dwivedi,et al.  Regional Distribution and Relative Abundance of Serotonin2c Receptors in Human Brain: Effect of Suicide , 2006, Neurochemical Research.

[96]  C. Benkelfat,et al.  Serotonin 1A Receptor Activation and Hypothermia in Humans: Lack of Evidence for a Presynaptic Mediation , 2002, Neuropsychopharmacology.

[97]  Mary L. Schneider,et al.  An in vivo comparison of cis- and trans-[18F]mefway in the nonhuman primate. , 2011, Nuclear medicine and biology.

[98]  A. Meneses,et al.  The effects of the 5-HT6 receptor agonist EMD and the 5-HT7 receptor agonist AS19 on memory formation , 2008, Behavioural Brain Research.

[99]  N. Volkow,et al.  Strategy for the Formation of Parametric Images under Conditions of Low Injected Radioactivity Applied to PET Studies with the Irreversible Monoamine Oxidase a Tracers [11C]Clorgyline and Deuterium-Substituted [11C]Clorgyline , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[100]  Jeffrey H Meyer,et al.  Imaging the serotonin transporter during major depressive disorder and antidepressant treatment. , 2007, Journal of psychiatry & neuroscience : JPN.

[101]  Jian Liu,et al.  The pyramidal neurons in the medial prefrontal cortex show decreased response to 5-hydroxytryptamine-3 receptor stimulation in a rodent model of Parkinson's disease , 2011, Brain Research.

[102]  T. Blackburn,et al.  Evidence for expression of the 5-hydroxytryptamine-2B receptor protein in the rat central nervous system , 1997, Neuroscience.

[103]  A. Sleight,et al.  Correlation between 5-HT7 receptor affinity and protection against sound-induced seizures in DBA/2J mice , 1997, Naunyn-Schmiedeberg's Archives of Pharmacology.

[104]  M. Ferrari,et al.  Selective seratonin 1F (5-HT1F) receptor agonist LY334370 for acute migraine: a randomised controlled trial , 2001, The Lancet.

[105]  Jun Li,et al.  [Association of 5-HT(2A) receptor polymorphism and attention deficit hyperactivity disorder in children]. , 2002, Zhonghua yi xue za zhi.

[106]  M. Bergström,et al.  11C-harmine as a tracer for monoamine oxidase A (MAO-A): in vitro and in vivo studies. , 1997, Nuclear medicine and biology.

[107]  F. Vollenweider,et al.  Psychological and Physiological Effects of MDMA (“Ecstasy”) after Pretreatment with the 5-HT2 Antagonist Ketanserin in Healthy Humans , 2000, Neuropsychopharmacology.

[108]  F. Mauguière,et al.  PET imaging of brain 5-HT1A receptors in the preoperative evaluation of temporal lobe epilepsy. , 2008, Brain : a journal of neurology.

[109]  J. Neumaier,et al.  Reduced ventral striatal/ventral pallidal serotonin1B receptor binding potential in major depressive disorder , 2011, Psychopharmacology.

[110]  Alan A. Wilson,et al.  Distribution of Vesicular Monoamine Transporter 2 Protein in Human Brain: Implications for Brain Imaging Studies , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[111]  M. Seidel,et al.  Differential pharmacotherapy for subgroups of fibromyalgia patients with specific consideration of 5-HT3 receptor antagonists , 2011, Expert opinion on pharmacotherapy.

[112]  M. Buhot,et al.  Hyperfunction of Muscarinic Receptor Maintains Long-Term Memory in 5-HT4 Receptor Knock-Out Mice , 2010, PloS one.

[113]  R. Davidson,et al.  In vivo kinetics of [F‐18]MEFWAY: A comparison with [C‐11]WAY100635 and [F‐18]MPPF in the nonhuman primate , 2011, Synapse.

[114]  C. Halldin,et al.  Quantitative Analysis of [11C]AZ10419369 Binding to 5-HT1B Receptors in Human Brain , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[115]  F. Dauphin,et al.  Serotonin 5-HT6 receptor blockade reverses the age-related deficits of recognition memory and working memory in mice , 2011, Behavioural Brain Research.

[116]  Morten L. Kringelbach,et al.  The personality trait openness is related to cerebral 5-HTT levels , 2009, NeuroImage.

[117]  S. Cichon,et al.  Investigation of the human serotonin 6 [5-HT6] receptor gene in bipolar affective disorder and schizophrenia. , 2000, American journal of medical genetics.

[118]  Claus Svarer,et al.  Brain imaging of serotonin 4 receptors in humans with [11C]SB207145-PET , 2010, NeuroImage.

[119]  H. Diener,et al.  Acute treatment of migraine with the selective 5-HT1F receptor agonist lasmiditan – A randomised proof-of-concept trial , 2010, Cephalalgia : an international journal of headache.

[120]  Siegfried Kasper,et al.  Multimodal imaging of human early visual cortex by combining functional and molecular measurements with fMRI and PET , 2008, NeuroImage.

[121]  J. Mann,et al.  Substance Abuse Disorder and Major Depression are Associated with the Human 5-HT1B Receptor Gene (HTR1B) G861C Polymorphism , 2003, Neuropsychopharmacology.

[122]  Y. Ohno Therapeutic Role of 5‐HT1A Receptors in The Treatment of Schizophrenia and Parkinson's Disease , 2011, CNS neuroscience & therapeutics.

[123]  Pedro Rosa-Neto,et al.  Stability of α-[11C]methyl-l-tryptophan brain trapping in healthy male volunteers , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[124]  Anders Ettrup,et al.  Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT2A agonist PET tracers , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[125]  G. Godeheu,et al.  Paradoxical constitutive behavioral sensitization to amphetamine in mice lacking 5-HT2A receptors , 2007, Psychopharmacology.

[126]  Rupert Lanzenberger,et al.  Cortisol plasma levels in social anxiety disorder patients correlate with serotonin-1A receptor binding in limbic brain regions. , 2010, The international journal of neuropsychopharmacology.

[127]  J. Ehlen,et al.  In Vivo Resetting of the Hamster Circadian Clock by 5-HT7 Receptors in the Suprachiasmatic Nucleus , 2001, The Journal of Neuroscience.

[128]  Victor W Pike,et al.  5‐HT radioligands for human brain imaging with PET and SPECT , 2013, Medicinal research reviews.

[129]  H. Hasegawa,et al.  Tryptophan hydroxylase and serotonin synthesis regulation , 2020, Handbook of Behavioral Neuroscience.

[130]  A. Wesołowska,et al.  The 5-HT6 receptor agonist EMD 386088 produces antidepressant and anxiolytic effects in rats after intrahippocampal administration , 2011, Psychopharmacology.

[131]  David C. Reutens,et al.  Increased serotonin receptor availability in human sleep: Evidence from an [18F]MPPF PET study in narcolepsy , 2006, NeuroImage.

[132]  Alan A. Wilson,et al.  Influence of a low dose of amphetamine on vesicular monoamine transporter binding: A PET (+)[11C]DTBZ study in humans , 2010, Synapse.

[133]  Abraham Weizman,et al.  Decreased platelet vesicular monoamine transporter density in habitual smokers , 2005, European Neuropsychopharmacology.

[134]  D. Murphy,et al.  Primary structure of the serotonin transporter in unipolar depression and bipolar disorder , 1995, Biological Psychiatry.

[135]  Ceri H. Davies,et al.  SB-699551-A (3-cyclopentyl-N-[2-(dimethylamino)ethyl]-N-[(4′-{[(2-phenylethyl)amino]methyl}-4-biphenylyl)methyl]propanamide dihydrochloride), a novel 5-ht5A receptor-selective antagonist, enhances 5-HT neuronal function: Evidence for an autoreceptor role for the 5-ht5A receptor in guinea pig brain , 2006, Neuropharmacology.

[136]  D. S. Cowen,et al.  5-HT7 receptors activate the mitogen activated protein kinase extracellular signal related kinase in cultured rat hippocampal neurons , 2001, Neuroscience.

[137]  W. Baaré,et al.  Cognitive function is related to fronto-striatal serotonin transporter levels – a brain PET study in young healthy subjects , 2011, Psychopharmacology.

[138]  V. Pike,et al.  Synthesis, structure-affinity relationships, and radiolabeling of selective high-affinity 5-HT4 receptor ligands as prospective imaging probes for positron emission tomography. , 2010, Journal of medicinal chemistry.

[139]  G. Kranz,et al.  Reward and the serotonergic system , 2010, Neuroscience.

[140]  Á. N. Chonchubhair Selective serotonin reuptake inhibitors. , 1998, Anaesthesia.

[141]  R. Silvestri,et al.  Radiosynthesis and in vivo evaluation of [11C]-labelled pyrrole-2-carboxamide derivates as novel radioligands for PET imaging of monoamine oxidase A. , 2010, Nuclear medicine and biology.

[142]  S. Leal,et al.  Novel and previously reported single-nucleotide polymorphisms in the human 5-HT(1B) receptor gene: no association with cocaine or alcohol abuse or dependence. , 2001, American journal of medical genetics.

[143]  P F Liddle,et al.  Effects of rapid tryptophan depletion on brain 5-HT2 receptors: a PET study , 2001, British Journal of Psychiatry.

[144]  G. Miller,et al.  Nonmotor Symptoms of Parkinson's Disease Revealed in an Animal Model with Reduced Monoamine Storage Capacity , 2009, The Journal of Neuroscience.

[145]  Giovanna Rizzo,et al.  5-HT2A receptor binding is reduced in drug-naive and unchanged in SSRI-responder depressed patients compared to healthy controls: a PET study , 2003, Psychopharmacology.

[146]  Claus Svarer,et al.  Cerebral 5-HT2A receptor binding is increased in patients with Tourette's syndrome. , 2007, The international journal of neuropsychopharmacology.

[147]  Richard E Carson,et al.  Kinetic Modeling of the Serotonin 5-HT1B Receptor Radioligand [11C]P943 in Humans , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[148]  Peter Herscovitch,et al.  Reduced Serotonin Type 1A Receptor Binding in Panic Disorder , 2004, The Journal of Neuroscience.

[149]  S. Tsai,et al.  Association analysis of the 5-HT6 receptor polymorphism C267T in Alzheimer's disease , 1999, Neuroscience Letters.

[150]  J. Sutcliffe,et al.  The 5-HT7 receptor influences stereotypic behavior in a model of obsessive-compulsive disorder , 2007, Neuroscience Letters.

[151]  D. Pandey,et al.  Design, synthesis and structure-activity relationship of novel quinoxalin-2-carboxamides as 5-HT3 receptor antagonists for the management of depression. , 2010, Bioorganic & medicinal chemistry letters.

[152]  Zsolt Szabo,et al.  Quantitative PET Studies of the Serotonin Transporter in MDMA Users and Controls Using [11C]McN5652 and [11C]DASB , 2005, Neuropsychopharmacology.

[153]  J. Palacios,et al.  Serotonin receptors in the human brain—III. Autoradiographic mapping of serotonin-1 receptors , 1987, Neuroscience.

[154]  Ramin V. Parsey,et al.  Elevated Serotonin 1A Binding in Remitted Major Depressive Disorder: Evidence for a Trait Biological Abnormality , 2009, Neuropsychopharmacology.

[155]  D. E. Nichols,et al.  Serotonin receptors. , 2008, Chemical reviews.

[156]  X. Codony,et al.  Selective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders. , 2008, Pharmacology & therapeutics.

[157]  T. Kozasa,et al.  Regulation and Physiological Functions of G12/13-Mediated Signaling Pathways , 2009, Neurosignals.

[158]  R Todd Ogden,et al.  Modeling Considerations for 11C-CUMI-101, an Agonist Radiotracer for Imaging Serotonin 1A Receptor In Vivo with PET , 2008, Journal of Nuclear Medicine.

[159]  Christine DeLorenzo,et al.  In Vivo Quantification of Human Serotonin 1A Receptor Using 11C-CUMI-101, an Agonist PET Radiotracer , 2010, The Journal of Nuclear Medicine.

[160]  C. Bai,et al.  Cytokines and serotonin transporter in patients with major depression , 2006, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[161]  D. Popa,et al.  Contribution of 5-HT2 Receptor Subtypes to Sleep–Wakefulness and Respiratory Control, and Functional Adaptations in Knock-Out Mice Lacking 5-HT2A Receptors , 2005, The Journal of Neuroscience.

[162]  Vibe G. Frokjaer,et al.  Serotonin transporter binding in the hypothalamus correlates negatively with tonic heat pain ratings in healthy subjects: A [11C]DASB PET study , 2011, NeuroImage.

[163]  V. Erspamer,et al.  Identification of Enteramine, the Specific Hormone of the Enterochromaffin Cell System, as 5-Hydroxytryptamine , 1952, Nature.

[164]  N. Volkow,et al.  Translational Neuroimaging: Positron Emission Tomography Studies of Monoamine Oxidase , 2005, Molecular Imaging and Biology.

[165]  C. Rowe,et al.  In Vivo Measurement of Vesicular Monoamine Transporter Type 2 Density in Parkinson Disease with 18F-AV-133 , 2010, Journal of Nuclear Medicine.

[166]  Robert B. Innis,et al.  Effects of Early Life Stress on [11C]DASB Positron Emission Tomography Imaging of Serotonin Transporters in Adolescent Peer- and Mother-Reared Rhesus Monkeys , 2006, The Journal of Neuroscience.

[167]  J. Holenz,et al.  Medicinal chemistry strategies to 5-HT(6) receptor ligands as potential cognitive enhancers and antiobesity agents. , 2006, Drug discovery today.

[168]  R. Parsey,et al.  Higher Serotonin 1A Binding in a Second Major Depression Cohort: Modeling and Reference Region Considerations , 2010, Biological Psychiatry.

[169]  M. Yeager,et al.  Candidate genes for anorexia nervosa in the 1p33–36 linkage region: serotonin 1D and delta opioid receptor loci exhibit significant association to anorexia nervosa* , 2003, Molecular Psychiatry.

[170]  T. Branchek,et al.  Characterization of LY344864 as a pharmacological tool to study 5-HT1F receptors: binding affinities, brain penetration and activity in the neurogenic dural inflammation model of migraine. , 1997, Life sciences.

[171]  P. Bonaventure,et al.  5-HT7 receptor deletion enhances REM sleep suppression induced by selective serotonin reuptake inhibitors, but not by direct stimulation of 5-HT1A receptor , 2009, Neuropharmacology.

[172]  Otto Muzik,et al.  Human brain serotonin synthesis capacity measured in vivo with α‐[C‐11]methyl‐L‐tryptophan , 1998 .

[173]  M Diksic,et al.  Statistical mapping analysis of serotonin synthesis images generated in healthy volunteers using positron-emission tomography and alpha-[11C]methyl-L-tryptophan. , 2000, Journal of psychiatry & neuroscience : JPN.

[174]  Sylvain Houle,et al.  Positron Emission Tomography Quantification of [11C]-Harmine Binding to Monoamine Oxidase-A in the Human Brain , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[175]  Yogesh Kumar Dwivedi,et al.  Neuroprotective effect of a chuk-me-sun-dan on neurons from ischemic damage and neuronal cell toxicity. , 2006 .

[176]  D. Kupfer,et al.  Serotonin-1A receptor imaging in recurrent depression: replication and literature review. , 2007, Nuclear medicine and biology.

[177]  M. Grégoire,et al.  Cerebral Monoamine Oxidase A Inhibition in Tobacco Smokers Confirmed With PET and [11C]Befloxatone , 2009, Journal of clinical psychopharmacology.

[178]  S. Obayashi,et al.  Synthesis and preliminary PET study of the 5‐HT7 receptor antagonist [11C]DR4446 , 2002 .

[179]  E. Lacivita,et al.  Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders. , 2011, Pharmacology & therapeutics.

[180]  Pedro Rosa-Neto,et al.  Measurement of brain regional alpha-[11C]methyl-L-tryptophan trapping as a measure of serotonin synthesis in medication-free patients with major depression. , 2004, Archives of general psychiatry.

[181]  H. Kung,et al.  An improved radiosynthesis of [18F]AV-133: a PET imaging agent for vesicular monoamine transporter 2. , 2010, Nuclear Medicine and Biology.

[182]  B. Bondy,et al.  Association of 5-HT1B receptor gene and antisocial behavior in alcoholism , 2004, Journal of Neural Transmission.

[183]  N. Volkow,et al.  Comparison of monoamine oxidase a in peripheral organs in nonsmokers and smokers. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[184]  G. Kennett,et al.  Antidepressant-like action of 5-HT1A agonists and conventional antidepressants in an animal model of depression. , 1987, European journal of pharmacology.

[185]  A. Wesołowska Potential role of the 5-HT_6 receptor in depression and anxiety: an overview of preclinical data , 2010, Pharmacological reports : PR.

[186]  Flemming Andersen,et al.  Evaluation of the Novel 5-HT4 Receptor PET Ligand [11C]SB207145 in the Göttingen Minipig , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[187]  G. Simig,et al.  Medicinal chemistry of 5-HT5A receptor ligands: a receptor subtype with unique therapeutical potential. , 2010, Current topics in medicinal chemistry.

[188]  Berend Olivier,et al.  5-HT1B receptors and aggression: a review. , 2005, European journal of pharmacology.

[189]  Rupert Lanzenberger,et al.  The Serotonin-1A Receptor in Anxiety Disorders , 2009, Biological Psychiatry.

[190]  R Hen,et al.  Enhanced aggressive behavior in mice lacking 5-HT1B receptor. , 1994, Science.

[191]  Yong-Ku Kim,et al.  Association Study between 5-HT1A Receptor Gene C(-1019)G Polymorphism and Panic Disorder in a Korean Population , 2010, Psychiatry investigation.

[192]  R. Rodriguiz,et al.  Vmat2 Heterozygous Mutant Mice Display a Depressive-Like Phenotype , 2007, The Journal of Neuroscience.

[193]  Richard E Carson,et al.  High-resolution imaging of brain 5-HT 1B receptors in the rhesus monkey using [11C]P943. , 2010, Nuclear medicine and biology.

[194]  Zarrin Ghasemi,et al.  Synthesis of new N-heteroaryl derivatives of 4-pyrones from kojic acid based Baylis–Hillman acetates , 2013, Chemistry of Heterocyclic Compounds.

[195]  M. Laruelle,et al.  Evaluation of the novel 5-HT6 receptor radioligand, [11C]GSK-215083 in human , 2008, NeuroImage.

[196]  R Tannock,et al.  The serotonin 5-HT1B receptor gene and attention deficit hyperactivity disorder , 2003, Molecular Psychiatry.

[197]  R. Yoshimura,et al.  Pharmacogenetic study of serotonin 6 receptor gene with antidepressant response in major depressive disorder in the Japanese population , 2010, Human psychopharmacology.

[198]  D. Le Bars,et al.  Synthesis and biological evaluation of potential 5-HT(7) receptor PET radiotracers. , 2011, European journal of medicinal chemistry.

[199]  David Goldman,et al.  Functional Genetic Variants that Increase Synaptic Serotonin and 5-HT3 Receptor Sensitivity Predict Alcohol and Drug Dependence , 2010, Molecular Psychiatry.

[200]  H. Meltzer The Role of Serotonin in Antipsychotic Drug Action , 1999, Neuropsychopharmacology.

[201]  M. Mandelkern,et al.  Neural and psychological predictors of treatment response in irritable bowel syndrome patients with a 5‐HT3 receptor antagonist: a pilot study , 2008, Alimentary pharmacology & therapeutics.

[202]  E. Marchetti-Gauthier,et al.  5-HT4 receptors: long-term blockade of K+ channels and effects on olfactory memory. , 1998, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

[203]  M. Macavoy,et al.  Regional distribution and behavioral correlates of 5-HT2A receptors in Alzheimer's disease with [18F]deuteroaltanserin and PET , 2009, Psychiatry Research: Neuroimaging.

[204]  P. Kalivas,et al.  Substance abuse disorders. , 2012, Handbook of clinical neurology.

[205]  M. Kung,et al.  Ketanserin and tetrabenazine abolish aggression in mice lacking monoamine oxidase A , 1999, Brain Research.

[206]  Lei Dong,et al.  Expression and role of 5-HT7 receptor in brain and intestine in rats with irritable bowel syndrome. , 2007, Chinese medical journal.

[207]  Lisa Weissfeld,et al.  Altered brain serotonin 5-HT1A receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [carbonyl11C]WAY-100635. , 2005, Archives of general psychiatry.

[208]  H. Nagawa,et al.  Antiangiogenic effect of a selective 5-HT4 receptor agonist. , 2010, The Journal of surgical research.

[209]  J. Witkin,et al.  Constitutive deletion of the serotonin-7 (5-HT7) receptor decreases electrical and chemical seizure thresholds , 2007, Epilepsy Research.

[210]  A. Meneses,et al.  5-HT1A receptors and memory , 2007, Neuroscience & Biobehavioral Reviews.

[211]  Paul Cumming,et al.  Effect of monoamine oxidase inhibition on amphetamine‐evoked changes in dopamine receptor availability in the living pig: A dual tracer PET study with [11C]harmine and [11C]raclopride , 2006, Synapse.

[212]  Julie C Price,et al.  Reduced 5-HT2A receptor binding after recovery from anorexia nervosa , 2002, Biological Psychiatry.

[213]  G. Fischbach,et al.  Neurotransmitters decrease the calcium conductance activated by depolarization of embryonic chick sensory neurones. , 1981, The Journal of physiology.

[214]  Jeih-San Liow,et al.  PET [11C]DASB imaging of serotonin transporters in patients with alcoholism. , 2007, Alcoholism, clinical and experimental research.

[215]  R. Narendran,et al.  Positron emission tomography imaging of amphetamine‐induced dopamine release in the human cortex: A comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride , 2009, Synapse.